Dr. Kulasekararaj shares results from a phase III study comparing ravulizumab with eculizumab in patients with paroxysmal nocturnal hemoglobinuria.
Негізгі бет Austin Kulasekararaj: A New Treatment Option for PNH?
Dr. Kulasekararaj shares results from a phase III study comparing ravulizumab with eculizumab in patients with paroxysmal nocturnal hemoglobinuria.
Пікірлер: 23